Randomized controlled trial of aerobic exercise on insulin and insulin-like growth factors in breast cancer survivors: The yale exercise and survivorship study

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 1, 2009, Pages 306-313

  Irwin, Melinda L ^a   Varma, Katie ^a   Alvarez Reeves, Marty ^c   Cadmus, Lisa ^a   Wiley, Andrew ^a   Chung, Gina G ^a   DiPietro, Loretta ^a,b   Mayne, Susan T ^a   Yu, Herbert ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHN B PIERCE LABORATORY   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3;

ADULT; AEROBIC EXERCISE; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; BREAST CANCER; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; CANCER SURVIVOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE INTENSITY; FEMALE; HORMONAL THERAPY; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ABSORPTIOMETRY, PHOTON; ANTHROPOMETRY; BONE DENSITY; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXERCISE; FEMALE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; LINEAR MODELS; MIDDLE AGED; QUESTIONNAIRES; RISK; SOMATOMEDINS; SURVIVORS;

EID: 58349083684     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0531     Document Type: Article

References (36)

1. Goodwin P, Ennis M, Pritchard K, et al. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 2002;20:42-51.
2. Pollak MN, Chapman JW, Shepherd L, et al. Insulin resistance, estimated by serum C-peptide level, is associated with reduced event-free survival for postmenopausal women in NCIC CTG MA.14 adjuvant breast cancer trial. J Clin Oncol 2006;24:9s, (suppl 18S, abstr 524).
3. Irwin ML, Ballard-Barbash R, McTiernan A, et al. Fasting C-peptide levels and breast cancer death. American Association of Cancer Research Frontiers in Cancer Prevention Meeting, December 2007. Abstract B99.
4. Irwin ML, McTiernan A, Bernstein L, et al. Relationship of obesity and physical activity with c-peptide, leptin, and insulin-like growth factors in breast cancer survivors. Cancer Epidemiol Biomarkers Prev 2005;14:2881-8.
5. Abrahamson PE, Gammon MD, Lund MJ, et al. General and abdominal obesity and survival among young women with breast cancer. Cancer Epidemiol Biomarkers Prev 2006;15:1871-7.
6. Chlebowski R, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol 2002;20:1128-43.
7. Holmes MD, Chen WY, Feskanich D, et al. Physical activity and survival after breast cancer diagnosis. JAMA 2005;293:2479-86.
8. Holick CN, Newcomb PA, Trentham-Dietz A, et al. Physical activity and survival after diagnosis of invasive breast cancer. Cancer Epidemiol Biomarkers Prev 2008;17:379-86. Epub 2008 Feb 4.
9. Irwin ML, Smith A, McTiernan A, et al. Association between pre- and post-diagnosis physical activity and mortality in breast cancer survivors. J Clin Oncol 2008;26:3958-64.
10. Goodwin PJ. Insulin in the adjuvant breast cancer setting: a novel therapeutic target for lifestyle and pharmacologic interventions? J Clin Oncol 2008;26:833-4.
11. Ligibel JA, Campbell N, Partridge A, et al. Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors. J Clin Oncol 2008;26:907-12.
12. Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial. Cancer Epidemiol Biomarkers Prev 2003;12:721-7.
13. Schmitz K, Rehana Ahmed, Hannan P, Yee D. Safety and efficacy of weight training in recent breast cancer survivors to alter body composition, insulin, and insulin-like growth factor axis proteins. Cancer Epidemiol Biomarkers Prev 2005;14:1672-80.
14. Yu H, Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 2000;92:1472-89.
15. Werner H, Weinstein D, Bentov I. Similarities and differences between insulin and IGF-I: structures, receptors, and signaling pathways. Arch Physiol Biochem 2008;114:17-22.
16. Hankinson SE, Willett WC, Colditz GA, et al. Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer. Lancet 1998;351:1393-6.
17. Vadgama JV, Wu Y, Datta G, Khan H, Chillar R. Plasma insulin-like growth factor-I and serum IGF-binding protein 3 can be associated with the progression of breast cancer, and predict the risk of recurrence and the probability of survival in African-American and Hispanic women. Oncology 1999;57:330-40.
18. Goodwin PJ, Ennis M, Pritchard KI, et al. Insulin-like growth factor binding proteins 1 and 3 and breast cancer outcomes. Breast Cancer Res Treat 2002;74:65-76.
19. McTiernan A, Sorensen B, Yasui Y, et al. No effect of exercise on insulin-like growth factor 1 and insulin-like growth factor binding protein 3 in postmenopausal women: a 12-month randomized controlled trial. Cancer Epidemiol Biomarkers Prev 2005;14:1020-1.
20. Orenstein MR, Friedenreich CM. Review of physical activity and the IGF family. J Phys Act Health 2004;1:291-320.
21. Irwin ML, Alvarez-Reeves M, Cadmus L, et al. Recruiting and retaining breast cancer survivors into a randomized controlled exercise trial: the Yale Exercise and Survivorship Study. Cancer 2008;112:2593-606.
22. Irwin ML, Alvarez-Reeves M, Cadmus L, et al. Effect of exercise on body fat, lean mass, and bone mineral density in breast cancer survivors. Obesity. In press 2009.
23. Kriska A, Knowler W, LaPorte R, et al. Development of a questionnaire to examine relationship of physical activity and diabetes in Pima Indians. Diabetes Care 1990;13:401-11.
24. Irwin ML, Tworoger SS, Yasui Y, et al. Influence of demographic, physiologic, and psychosocial variables on adherence to a yearlong moderate-intensity exercise trial in postmenopausal women. Prev Med 2004;39:1080-6.
25. Bassett D, Ainsworth B, Leggett S, et al. Accuracy of five electronic pedometers for measuring distance walked. Med Sci Sports Exerc 1996;28:1071-7.
26. Ainsworth BE, Haskell WL, Whitt MC, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000;32:S498-504.
27. Van Loan MD, Mayclin PL. Body composition assessment: dual energy X-ray absorptiometry for total body and regional bone mineral and soft tissue composition. Eur J Clin Nutr 1992;46:174-8.
28. Patterson RE, Kristal AR, Tinker LF, et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol 1999;9:178-87.
29. Pate R, Ettinger W, Heath GW, et al. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 1995;273:402-7.
30. Irwin ML, McTiernan A, Bernstein L, et al. Physical activity levels among breast cancer survivors. Med Sci Sports Exerc 2004;36:1484-91.
31. Bonanni B, Johansson H, Gandini S, et al. Effect of low dose tamoxifen on the IGF system in healthy women. Breast Cancer Res Treat 2001;69:21-7.
32. Frank LL, Sorensen BE, Yasui Y, et al. Effects of exercise on metabolic risk variables in overweight postmenopausal women: a randomized clinical trial. Obes Res 2005;13:615-25.
33. Gomez JM. Serum leptin, insulin-like growth factor-I components and sex hormone binding globulin. Relationship with sex, age and body composition in healthy population. Protein Pept Lett 2007;14:708-11.
34. Yu H, Levesque MA, Khosravi MJ, et al. Insulin-like growth factor-binding protein-3 and breast cancer survival. Int J Cancer 1998;79:624-8.
35. Allen NE, Roddam AW, Allen DS, et al. A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk. Br J Cancer 2005;92:1283-7.
36. Goodyear L, Kahn B. Exercise, glucose transport, and insulin sensitivity. Annu Rev Med 1998;49:235-61.